These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28425256)
61. Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome. Tsao PN; Wei SC; Su YN; Lee CN; Chou HC; Hsieh WS; Hsieh FJ Pediatrics; 2004 May; 113(5):1348-51. PubMed ID: 15121952 [TBL] [Abstract][Full Text] [Related]
62. Decreased neutrophil levels in bronchopulmonary dysplasia infants. Li X; Wang Q; Luo T; Li T Pediatr Neonatol; 2020 Dec; 61(6):637-644. PubMed ID: 32863167 [TBL] [Abstract][Full Text] [Related]
64. Vitamin D and bronchopulmonary dysplasia in preterm infants. Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562 [TBL] [Abstract][Full Text] [Related]
65. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia. Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203 [TBL] [Abstract][Full Text] [Related]
66. Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. Wai KC; Kohn MA; Ballard RA; Truog WE; Black DM; Asselin JM; Ballard PL; Rogers EE; Keller RL; J Pediatr; 2016 Oct; 177():97-102.e2. PubMed ID: 27470692 [TBL] [Abstract][Full Text] [Related]
67. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
68. N-terminal propeptide of type III collagen in tracheal fluid and serum in preterm infants at risk for bronchopulmonary dysplasia. Heikinheimo M; Halila R; Marttinen E; Raivio K Pediatr Res; 1992 Apr; 31(4 Pt 1):340-3. PubMed ID: 1570200 [TBL] [Abstract][Full Text] [Related]
69. Platelet is the early predictor of bronchopulmonary dysplasia in very premature infants: an observational cohort study. Wang X; Ma Y; Wang S; Dong W; Lei X BMC Pulm Med; 2022 Mar; 22(1):109. PubMed ID: 35346143 [TBL] [Abstract][Full Text] [Related]
70. Early metabolic markers as predictors of respiratory complications in preterm infants with bronchopulmonary dysplasia. You Y; Wang L; Liu C; Wang X; Zhou L; Zhang Y; Xia H Early Hum Dev; 2024 Mar; 190():105950. PubMed ID: 38301336 [TBL] [Abstract][Full Text] [Related]
71. Association between blood carboxyhemoglobin level and bronchopulmonary dysplasia in extremely low birthweight infants. Tagliaferro T; Cayabyab R; Ramanathan R J Investig Med; 2022 Jan; 70(1):68-72. PubMed ID: 34493626 [TBL] [Abstract][Full Text] [Related]
72. Serum cytokine concentrations, chorioamnionitis and the onset of bronchopulmonary dysplasia in premature infants. Kaneko M; Sato M; Ogasawara K; Imamura T; Hashimoto K; Momoi N; Hosoya M J Neonatal Perinatal Med; 2017; 10(2):147-155. PubMed ID: 28409755 [TBL] [Abstract][Full Text] [Related]
73. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia. van Mastrigt E; Zweekhorst S; Bol B; Tibboel J; van Rosmalen J; Samsom JN; Kroon AA; de Jongste JC; Reiss IKM; Post M; Pijnenburg MW PLoS One; 2018; 13(1):e0185969. PubMed ID: 29346372 [TBL] [Abstract][Full Text] [Related]
74. Urinary β2-microglobulin and bronchopulmonary dysplasia: Trends in preterm infants. Shima Y; Kumasaka S; Nishimaki S Pediatr Int; 2017 Nov; 59(11):1169-1173. PubMed ID: 28833913 [TBL] [Abstract][Full Text] [Related]
75. The development of lung biochemical monitoring can play a key role in the early prediction of bronchopulmonary dysplasia. Fabiano A; Gavilanes AW; Zimmermann LJ; Kramer BW; Paolillo P; Livolti G; Picone S; Bressan K; Gazzolo D Acta Paediatr; 2016 May; 105(5):535-41. PubMed ID: 26439807 [TBL] [Abstract][Full Text] [Related]
76. Early versus late identification of infants at high risk of developing moderate to severe bronchopulmonary dysplasia. Rozycki HJ; Narla L Pediatr Pulmonol; 1996 Jun; 21(6):345-52. PubMed ID: 8927460 [TBL] [Abstract][Full Text] [Related]
77. Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1. Ramsay PL; O'Brian Smith E; Hegemier S; Welty SE Pediatrics; 1998 Oct; 102(4 Pt 1):927-32. PubMed ID: 9755267 [TBL] [Abstract][Full Text] [Related]
78. A clinical scoring system to predict the development of bronchopulmonary dysplasia. Gursoy T; Hayran M; Derin H; Ovali F Am J Perinatol; 2015 Jun; 32(7):659-66. PubMed ID: 25285400 [TBL] [Abstract][Full Text] [Related]
79. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Choi CW; Kim BI; Kim HS; Park JD; Choi JH; Son DW Acta Paediatr; 2006 Jan; 95(1):38-43. PubMed ID: 16373294 [TBL] [Abstract][Full Text] [Related]
80. Association between anemia and bronchopulmonary dysplasia in preterm infants. Duan J; Kong X; Li Q; Hua S; Zhang S; Zhang X; Feng Z Sci Rep; 2016 Mar; 6():22717. PubMed ID: 26936610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]